Pfizer’s bladder cancer treatment achieves main goal in late-stage trial
Jeenah Moon/Getty Images News Pfizer (NYSE:PFE) said on Friday it achieved main goal in late-stage
Jeenah Moon/Getty Images News Pfizer (NYSE:PFE) said on Friday it achieved main goal in late-stage
solidcolours Astellas (OTCPK:ALPMY) (OTCPK:ALPMF) announced Wednesday that Chinese regulators approved its antibody-drug conjugate Padcev, developed
Hailshadow The U.S. FDA is ordering that respiratory syncytial virus (RSV) vaccines marketed by GSK
angelp Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as
JUN LI The Louisiana Department of Health has reported the first death in the U.S.
KanawatTH While the S&P 500’s (SP500) surge in 2024 logged a milestone of annual gains
Summary: Pfizer’s stock has plummeted due to declining COVID-19 sales, expected patent losses, and political
Jeenah Moon/Getty Images News Pfizer (NYSE:PFE) has entered into a collaborative research agreement with Atavistik
Summary: Pfizer targets $4 billion in operational savings by 2024, improving margins and driving long-term
Pixelimage The price of branded prescription drugs will rise an average of 4.5% in 2025,